Qinghai Spring Medicinal Resources Technology Co Ltd Total Liabilities

Latest as of March 2026: CN¥36.47 Million CNY ≈ $5.34 Million USD

Qinghai Spring Medicinal Resources Technology Co Ltd total liabilities. Based on the latest financial reports, Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has total liabilities worth CN¥36.47 Million CNY (≈ $5.34 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Qinghai Spring Medicinal Resources Techn to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Qinghai Spring Medicinal Resources Technology Co Ltd (1998–2025)

Total liabilities of Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2025. This chart illustrates how Qinghai Spring Medicinal Resources Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore investment intensity of Qinghai Spring Medicinal Resources Techn to see how much of total assets are deployed in long-term investments.

Qinghai Spring Medicinal Resources Technology Co Ltd Competitors by Total Liabilities

The table below lists competitors of Qinghai Spring Medicinal Resources Technology Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
NL Industries Inc
NYSE:NL
USA $88.73 Million
International CSRC Investment Holdings Co Ltd
TW:2104
Taiwan NT$22.94 Billion
Radiant Logistics Inc
NYSE MKT:RLGT
USA $218.17 Million
Qtone Education Group Guangdong Ltd
SHE:300359
China CN¥142.73 Million
Fossil Group Inc
NASDAQ:FOSL
USA $330.72 Million
North American Construction Group Ltd
TO:NOA
Canada CA$1.40 Billion
AVIT Ltd
SHE:300264
China CN¥201.71 Million
Seoul Food
KO:004410
Korea ₩46.52 Billion

Liability Composition Analysis (1998–2025)

This chart breaks down Qinghai Spring Medicinal Resources Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Qinghai Spring Medicinal Resources Techn.

Liquidity & Leverage Metrics

Qinghai Spring Medicinal Resources Technology Co Ltd Total Liabilities Ratios Explained

Qinghai Spring Medicinal Resources Technology Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 17.66 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.04 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.04 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Qinghai Spring Medicinal Resources Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Qinghai Spring Medicinal Resources Technology Co Ltd (1998–2025)

The table below shows the annual total liabilities of Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥44.87 Million
≈ $6.57 Million
-64.96%
2024-12-31 CN¥128.02 Million
≈ $18.73 Million
+39.17%
2023-12-31 CN¥91.99 Million
≈ $13.46 Million
+249.80%
2022-12-31 CN¥26.30 Million
≈ $3.85 Million
-4.85%
2021-12-31 CN¥27.64 Million
≈ $4.04 Million
-79.84%
2020-12-31 CN¥137.08 Million
≈ $20.06 Million
+580.80%
2019-12-31 CN¥20.14 Million
≈ $2.95 Million
-61.78%
2018-12-31 CN¥52.68 Million
≈ $7.71 Million
-53.61%
2017-12-31 CN¥113.56 Million
≈ $16.62 Million
-45.13%
2016-12-31 CN¥206.95 Million
≈ $30.28 Million
-41.64%
2015-12-31 CN¥354.60 Million
≈ $51.89 Million
-68.53%
2014-12-31 CN¥1.13 Billion
≈ $164.88 Million
-21.69%
2013-12-31 CN¥1.44 Billion
≈ $210.56 Million
-24.25%
2012-12-31 CN¥1.90 Billion
≈ $277.97 Million
+17.40%
2011-12-31 CN¥1.62 Billion
≈ $236.77 Million
+72.39%
2010-12-31 CN¥938.58 Million
≈ $137.34 Million
+78.57%
2009-12-31 CN¥525.60 Million
≈ $76.91 Million
-10.77%
2008-12-31 CN¥589.02 Million
≈ $86.19 Million
-16.76%
2007-12-31 CN¥707.61 Million
≈ $103.55 Million
-18.04%
2006-12-31 CN¥863.38 Million
≈ $126.34 Million
-17.39%
2005-12-31 CN¥1.05 Billion
≈ $152.93 Million
-14.60%
2004-12-31 CN¥1.22 Billion
≈ $179.07 Million
+54.93%
2003-12-31 CN¥789.85 Million
≈ $115.58 Million
+89.91%
2002-12-31 CN¥415.90 Million
≈ $60.86 Million
+56.98%
2001-12-31 CN¥264.94 Million
≈ $38.77 Million
+41.00%
2000-12-31 CN¥187.91 Million
≈ $27.50 Million
+46.76%
1999-12-31 CN¥128.04 Million
≈ $18.74 Million
+7.16%
1998-12-31 CN¥119.48 Million
≈ $17.48 Million
--

About Qinghai Spring Medicinal Resources Technology Co Ltd

SHG:600381 China Drug Manufacturers - Specialty & Generic
Market Cap
$329.88 Million
CN¥2.25 Billion CNY
Market Cap Rank
#14061 Global
#4122 in China
Share Price
CN¥3.84
Change (1 day)
-0.52%
52-Week Range
CN¥2.61 - CN¥5.70
All Time High
CN¥24.91
About

Qinghai Spring Medicinal Resources Technology Co., Ltd. manufactures and sells alcoholic beverages and health products in China. It operates through two segments, Wine and Beverage Fast-Moving Consumer Goods and Big Health. The Wine and Beverage Fast-Moving Consumer Goods segment focuses on the sales of alcoholic beverages, including the Tinghua series wines. The Big Health segment engages in the… Read more